WHO ICTRP trial
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept…
EUCTR2004-002629-36-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-002629-36-HU |
|---|---|
| Public title | A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEAREST |
| Scientific title | A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEAREST |
| Primary sponsor | Wyeth Pharmaceuticals, Global Medical Affairs Department |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland;Hungary;United Kingdom;Germany;Czech Republic;Denmark;Spain;Ireland;Italy;Sweden |
| Conditions | psoriasis |
| Interventions | Product Name: Etanercept Product Code: 0881 Pharmaceutical Form: Powder and solvent for solution for injection INN or Proposed INN: etanercept CAS Number: N/Applicable Current Sponsor code: 0881 Other descriptive name: TNR-001; TNFR:Fc; rhu… |
| Registration date | Dec 14, 2004 |
| Target size | 700 |
| Secondary IDs | 0881A6-101764 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: